Circulatory levels of ALT are elevated in people with type 2 diabetes (24) and metabolic syndrome (25), but lower in the presence of age-related syndromes often characterised by under-nutrition, including sarcopenia (26). This evidence concerns the gene GPT and type 2 diabetes mellitus.